Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-29

Clinical Trial Update: Botanical Tincture for Symptoms of Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial of a botanical tincture for irritable bowel syndrome with constipation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botanical tincture for IBS symptoms (trial product)

Snippet

Sponsor: Stamford Hospital | Conditions: Irritable Bowel Syndrome Characterized by Constipation | Phase 2 | Status: WITHDRAWN